Shahzad Malik
QuietNamed in filings at Advent Life SciencesOn the current fund
- Board seats filed
- 9
- Named on a board
- 0
all filings on record
Named in filings at Advent Life SciencesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Moximed | Medical devices | August 2024 | Lightstone Singapore, Lightstone Ventures, NEA |
| Iterum Therapeutics Bermuda | Biotech & pharma | January 2020 | Capra CLO Founders, New Leaf, Sofinnova Venture Partners |
| Iterum Therapeutics plc | Biotech & pharma | May 2017 | New Leaf |
| Axonics Modulation Technologies | Not yet classified | December 2015 | None on file |
| Nalu Medical | Not yet classified | June 2015 | None on file |
| AGENUS | Not yet classified | February 2015 | None on file |
| Versartis | Not yet classified | February 2014 | Samsara Biocapital |
| IDUN PHARMACEUTICALS | Biotech & pharma | February 2014 | MPM BioVentures |
| Acutus Medical | Medical devices | June 2013 | Orbimed Asia Partners, Orbimed Genesis |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Shahzad Malik on the board, based on 5 filed seats with a verified or cited source.
4 more filed seats not yet classified, left out of the shares above.